Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Search Results to Enrique Alvarez III

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Alvarez, Enrique

Item TypeName
Concept Multiple Sclerosis, Relapsing-Remitting
Concept Multiple Sclerosis, Chronic Progressive
Concept Multiple Sclerosis
Academic Article Severe anemia in a patient with multiple sclerosis treated with natalizumab.
Academic Article Should we start evaluating intrathecal IgM production clinically?
Academic Article Comparison of fingolimod and dimethyl fumarate in the treatment of multiple sclerosis: Two-year experience.
Academic Article Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis.
Academic Article Association of neuromyelitis optica with severe and intractable pain.
Academic Article The immunopathophysiology of multiple sclerosis.
Academic Article CXCL13 is a biomarker of inflammation in multiple sclerosis, neuromyelitis optica, and other neurological conditions.
Academic Article Detection of cortical lesions in multiple sclerosis: A new imaging approach.
Academic Article Predicting optimal response to B-cell depletion with rituximab in multiple sclerosis using CXCL13 index, magnetic resonance imaging and clinical measures.
Academic Article Pulse Width Does Not Influence the Gains Achieved With Neuromuscular Electrical Stimulation in People With Multiple Sclerosis: Double-Blind, Randomized Trial.
Academic Article Fingolimod's Impact on MRI Brain Volume Measures in Multiple Sclerosis: Results from MS-MRIUS.
Academic Article The impact of very short transition times on switching from Natalizumab to Fingolimod on imaging and clinical effectiveness outcomes in multiple sclerosis.
Academic Article CD40-Mediated NF-?B Activation in B Cells Is Increased in Multiple Sclerosis and Modulated by Therapeutics.
Academic Article Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.
Academic Article Impact of fingolimod on clinical and magnetic resonance imaging outcomes in routine clinical practice: A retrospective analysis of the multiple sclerosis, clinical and MRI outcomes in the USA (MS-MRIUS) study.
Academic Article We need to conduct clinical trials of disease-modifying therapy in pregnancy to optimize care of women with MS - Yes.
Academic Article Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal.
Academic Article Rituximab vs placebo induction prior to glatiramer acetate monotherapy in multiple sclerosis.
Academic Article Real-World Characterization of Dimethyl Fumarate-Related Gastrointestinal Events in Multiple Sclerosis: Management Strategies to Improve Persistence on Treatment and Patient Outcomes.
Academic Article Subjective cognitive concern in multiple sclerosis is associated with reduced thalamic and cortical gray matter volumes.
Academic Article Natalizumab versus fingolimod and dimethyl fumarate in multiple sclerosis treatment.
Academic Article Monoclonal Antibodies in Multiple Sclerosis: Present and Future.
Academic Article B cell depletion with ublituximab reshapes the T cell profile in multiple sclerosis patients.
Academic Article Rituximab-induced serum sickness in multiple sclerosis patients.
Academic Article Comparative discontinuation, effectiveness, and switching practices of dimethyl fumarate and fingolimod at 36-month follow-up.
Academic Article Sensory nerve stimulation causes an immediate improvement in motor function of persons with multiple sclerosis: A pilot study.
Academic Article Patient-reported outcomes in multiple sclerosis: Validation of the Quality of Life in Neurological Disorders (Neuro-QoL?) short forms.
Academic Article Rituximab versus natalizumab, fingolimod, and dimethyl fumarate in multiple sclerosis treatment.
Academic Article Serious safety events in rituximab-treated multiple sclerosis and related disorders.
Academic Article Safety results of administering ocrelizumab per a shorter infusion protocol in patients with primary progressive and relapsing multiple sclerosis.
Academic Article Brain Atrophy Rates for Stable Multiple Sclerosis Patients on Long-Term Fingolimod versus Glatiramer Acetate.
Academic Article Pandemic forward: Lessons learned and expert perspectives on multiple sclerosis care in the COVID-19 era.
Academic Article Movement compensations during a step ascent task are associated with stair climbing performance in people with multiple sclerosis.
Academic Article COVID-19 Vaccination in Patients With Multiple Sclerosis on Disease-Modifying Therapy.
Academic Article Multiple Sclerosis Progression Discussion Tool Usability and Usefulness in Clinical Practice: Cross-sectional, Web-Based Survey.
Academic Article Brain atrophy rates in patients with multiple sclerosis on long term natalizumab resembles healthy controls.
Academic Article Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study.
Academic Article Multiple Sclerosis Phenotypes as a Continuum: The Role of Neurologic Reserve.
Academic Article B cell depletion changes the immune cell profile in multiple sclerosis patients: One-year report.
Academic Article Treatment with electrical stimulation of sensory nerves improves motor function and disability status in persons with multiple sclerosis: A pilot study.
Academic Article Distinguishing between Fatigue and Fatigability in Multiple Sclerosis.
Academic Article Evolution of Disease Modifying Therapy Benefits and Risks: An Argument for De-escalation as a Treatment Paradigm for Patients With Multiple Sclerosis.
Academic Article Prognostic Value of Serum Neurofilament Light Chain for Disease Activity and Worsening in Patients With Relapsing Multiple Sclerosis: Results From the Phase 3 ASCLEPIOS I and II Trials.
Academic Article A double-blind, placebo-controlled, single-ascending-dose intravenous infusion study of rHIgM22 in subjects with multiple sclerosis immediately following a relapse.
Academic Article The CELLO trial: Protocol of a planned phase 4 study to assess the efficacy of Ocrelizumab in patients with radiologically isolated syndrome.
Academic Article Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.
Academic Article Safety and patient experience with at-home infusion of ocrelizumab for multiple sclerosis.
Academic Article Metabolic costs of walking and arm reaching in persons with mild multiple sclerosis.
Academic Article Multiple sclerosis plasma IgG aggregates induce complement-dependent neuronal apoptosis.
Academic Article Real-world cost of care and site of care in patients with multiple sclerosis initiating infused disease-modifying therapies.
Academic Article Development and usability testing of your MS questionnaire: A patient-based digital tool to monitor symptoms of multiple sclerosis.
Academic Article Secondary hypogammaglobulinemia in patients with multiple sclerosis on anti-CD20 therapy: Pathogenesis, risk of infection, and disease management.
Academic Article Feasibility of Low-Load Resistance Training Using Blood Flow Restriction for People With Advanced Multiple Sclerosis: A Prospective Cohort Study.
Academic Article Plasma IgG aggregates as biomarkers for multiple sclerosis.
Academic Article Implementing Shared Decision-Making for Multiple Sclerosis: The MS-SUPPORT Tool.
Academic Article Advances in Multiple Sclerosis Neurotherapeutics, Neuroprotection, and Risk Mitigation Strategies.
Academic Article Comparative Efficacy of Disease-Modifying Treatments for Relapsing Multiple Sclerosis-Variations in Real-World Experience.

Search Criteria
  • Sclerosis

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)